(6-{2-[3-(4-Phenylcarbamoyl)-5-(4-fluoro-phenyl)-2-isopropyl-4-phenyl-d5-pyrrol-1-yl]-ethyl}-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester
Share product
- structure.search.product.name (6-{2-[3-(4-Phenylcarbamoyl)-5-(4-fluoro-phenyl)-2-isopropyl-4-phenyl-d5-pyrrol-1-yl]-ethyl}-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester
- Numer katalogowy produktu: TRC-P319587
- Numer CAS: 265989-34-2
- Marka: TRC
Product Overview
Kod produktu
TRC-P319587
Numer CAS
Postać produktu
Neat
Wzór cząsteczkowy
C40H42D5FN2O5
Masa cząsteczkowa
659.84
Kategorie produktów
TRC, Stable isotopes, API Reference Standards & Research Materials
Nieoznakowany numer CAS
Informacje o produkcie
Chemical Data
Nazwa analitu
(6-(2-[3-(4-Phenylcarbamoyl)-5-(4-fluoro-phenyl)-2-isopropyl-4-phenyl-d5-pyrrol-1-yl]-ethyl)-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester
Numer CAS
265989-34-2
Wzór cząsteczkowy
C40H42D5FN2O5
Masa cząsteczkowa
659.84
Dokładna masa
659.3783
SMILES
[2H]c1c([2H])c([2H])c(c([2H])c1[2H])c2c(C(=O)Nc3ccccc3)c(C(C)C)n(CCC4CC(CC(=O)OC(C)(C)C)OC(C)(C)O4)c2c5ccc(F)cc5
InChI
InChI=1S/C40H47FN2O5/c1-26(2)36-35(38(45)42-30-16-12-9-13-17-30)34(27-14-10-8-11-15-27)37(28-18-20-29(41)21-19-28)43(36)23-22-31-24-32(47-40(6,7)46-31)25-33(44)48-39(3,4)5/h8-21,26,31-32H,22-25H2,1-7H3,(H,42,45)/i8D,10D,11D,14D,15D
IUPAC
tert-butyl 2-[6-[2-[2-(4-fluorophenyl)-3-(2,3,4,5,6-pentadeuteriophenyl)-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate
Nieoznakowany numer CAS
125971-95-1
Typ SIL
Deuterium
Dane produktu
Temperatura podczas transportu
Room Temperature
Kraj pochodzenia
CANADA
Rodzaj produktu
Stable Isotope Labelled; API
Postać produktu
Neat
Product Description
An deuterated intermediate of deuterated Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. The only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
References: Kearney, A.S., et al.: Pharm. Res., 10, 1461 (1993), Heinonen, T.M., et al.: Clin. Ther., 18. 853 (1996), Whitfield, L.R., et al.: Eur. J. Drug Metab. Pharmacokinet., 25, 97 (2000)